UNICYCIVE THERAPEUTICS INC's ticker is and the CUSIP is 90466Y103. A total of 11 filers reported holding UNICYCIVE THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $34,030 | -8.0% | 63,019 | 0.0% | 0.00% | +50.0% |
| Q3 2022 | $37,000 | -82.0% | 63,019 | -74.5% | 0.00% | -85.7% |
| Q2 2022 | $205,000 | -35.7% | 247,583 | 0.0% | 0.01% | -22.2% |
| Q1 2022 | $319,000 | -37.5% | 247,583 | 0.0% | 0.02% | -43.8% |
| Q4 2021 | $510,000 | -27.1% | 247,583 | 0.0% | 0.03% | -38.5% |
| Q3 2021 | $700,000 | – | 247,583 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ayrton Capital LLC | 76,645 | $158,000 | 0.15% |
| Nantahala Capital Management | 686,756 | $1,415,000 | 0.05% |
| Board of Trustees of The Leland Stanford Junior University | 247,583 | $510,000 | 0.03% |
| TANDEM CAPITAL MANAGEMENT CORP /ADV | 15,500 | $32,000 | 0.02% |
| Frontier Wealth Management LLC | 18,800 | $39,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 26,109 | $53,000 | 0.00% |
| MORGAN STANLEY | 2 | $0 | 0.00% |
| BlackRock Inc. | 16,045 | $33,000 | 0.00% |
| VANGUARD GROUP INC | 22,695 | $47,000 | 0.00% |